A complete application in a minute — tailored resume and cover letter, ready to send.
Apellis Pharmaceuticals, Inc. is seeking an Associate Director of Business Intelligence to drive market insights for SYFOVRE.
You will partner with US commercial teams to translate primary research, secondary data analysis, and competitive intelligence into integrated, actionable guidance for key stakeholders. Ideal candidates have 7+ years in pharma/biotech, advanced degree preferred, and proven skills in quantitative and qualitative research, vendor management, and executive storytelling.
Opportunity awaits those up to the challenge of developing transformative therapies across a broad range of debilitating diseases. Summary: We are looking for a talented and energetic Associate Director of Business Intelligence to join our team and drive the advancement of our business intelligence strategies and capabilities in support of SYFOVRE. The Associate Director of Business Intelligence will be accountable for partnering closely U.S. commercial teams to generate market-specific insights gathered from primary market research, secondary data analysis, and competitive intelligence to create integrated and actionable insights for key customer/stakeholder groups. The ideal candidate should have experience working in a commercial insights position within a biotech or pharmaceutical company. The Associate Director will report into the Senior Director of Business Intelligence for SYFOVRE and will serve as a key member of the SYFOVRE team to drive insights and market knowledge that will be critical to continue driving the success of the brand.
Qualifications B.S. degree required (business, biology, or medicine-related degree preferred). Advanced Degree (MBA, PhD, PharmD) preferred At least 7+ years of experience in pharmaceutical/biotech/medtech industry (client-side experience preferred)
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two C3-targeting medicines approved to treat four serious diseases. Breakthroughs for patients include the first-ever therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients 12 and older with C3G or primary IC-MPGN, two severe, rare kidney diseases. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases. For more information, please visit http://apellis.com or follow us on LinkedIn and X.
Please note this job description is not designed to cover or contain a comprehensive listing of activities, duties or responsibilities that are required of the employee for this job. Duties, responsibilities and activities may change at any time with or without notice. Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two C3-targeting medicines approved to treat four serious diseases. Breakthroughs for patients include the first-ever therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients 12 and older with C3G or primary IC-MPGN, two severe, rare kidney diseases. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases. For more information, please visit http://apellis.com or follow us on LinkedIn and X.